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An Enzymatic Activity in the Yeast Sir2 Protein
that Is Essential for Gene Silencing
that are inserted within the ribosomal DNA (rDNA) re-
peats, suggesting that a silencing-based mechanism
regulates rDNA chromatin structure (Bryk et al., 1997;
Jason C. Tanny,*§ Gustave J. Dowd,*§
Julie Huang,* Helmuth Hilz,²
and Danesh Moazed*³
*Department of Cell Biology Fritze et al., 1997; Smith and Boeke, 1997).
Harvard Medical School Many gene products have been identified that are
Boston, Massachusetts 02115 required for the assembly of silent chromatin in yeast
² Institut fuÈ r Medizinische Biochemie (e.g., Klar et al., 1979; Rine and Herskowitz, 1987; Shore
und Molekularbiologie and Nasmyth, 1987; Kayne et al., 1988; Foss et al., 1993;
UniversitaÈ tskrankenhaus Eppendorf Straight et al., 1999). Sir2 is unique among these gene
20246 Hamburg products in that it is required for all examples of silenc-
Germany ing. We and others have shown that Sir2 is a component
of two distinct complexes (Moretti et al., 1994; Moazed
and Johnson, 1996; Moazed et al., 1997; Strahl-Bol-
Summary singer et al., 1997). One complex contains the Sir2, Sir3,
and Sir4 proteins and mediates silencing at the silent
Despite its conservation in organisms from bacteria to mating±type loci and telomeric DNA regions (Moazed
human and its general requirement for transcriptional et al., 1997; Strahl-Bolsinger et al., 1997). A second com-
silencing in yeast, the function of the Sir2 protein is plex contains Sir2, Net1, and Cdc14 and is required for
unknown. Here we show that Sir2 can transfer labeled silencing at the rDNA repeats (Shou et al., 1999; Straight
phosphate from nicotinamide adenine dinucleotide to et al., 1999). The general requirement for Sir2 in silenc-
itself and histones in vitro. A modified form of Sir2, ing, together with the universal conservation of a 250
which results from its automodification activity, is spe- amino acid domain within Sir2 (Brachmann et al., 1995;
cifically recognized by anti-mono-ADP-ribose anti- Sherman et al., 1999), strongly suggests that it is in-
bodies, suggesting that Sir2 is an ADP-ribosyltransfer- volved in a key aspect of the mechanism of silencing.
ase. Mutation of a phylogenetically invariant histidine The role of Sir2 in silencing is unknown, but recent
residue in Sir2 abolishes both its enzymatic activity in evidence suggests that the conserved core domain in
vitro and its silencing functions in vivo. However, the Sir2-like proteins harbors an enzymatic activity that may
mutant protein is associated with chromatin and other involve the transfer of ADP-ribose from nicotinamide
silencing factors in a manner similar to wild-type Sir2. adenine dinucleotide (NAD1) to protein substrates (Frye,
These findings suggest that Sir2 contains an ADP- 1999). First, the Salmonella typhimurium Sir2-like pro-
ribosyltransferase activity that is essential for its si- tein, CobB, is required to compensate for the lack of
lencing function. CobT, a protein that functions in the cobalamine bio-
synthesis pathway as a nicotinate mononucleotide:
Introduction
5,6-dimethylbenzimidazole phosphoribosyltransferase
(Tsang and Escalante-Semerena, 1998). These results
Gene silencing involves the formation of a specialized
suggest that CobB may be able to perform a similar
chromatin structure that limits access to DNA by the
phosphoribosyltransferase reaction, explaining its ap-machineries that transcribe, replicate, and recombine
parent functional overlap with CobT. Second, two Sir2-the cell's genetic information. The physiological roles
like proteins from human and E. coli have been shownof silencing include the stable repression of gene ex-
to catalyze the transfer of 32P from 32P-NAD1 to bovinepression, a process that is important for maintaining
serum albumin (BSA) (Frye, 1999).the differentiated state of cells, and repression of hyper-
The biological roles of neither E. coli CobB nor anyrecombination in highly repetitive chromosome regions,
of the human Sir2-like proteins are known. Therefore,a process that plays a crucial role in maintaining chro-
clues regarding their possible substrates and any evi-mosome stability (reviewed in Loo and Rine, 1994; Lus-
dence that the observed activity is functionally signifi-tig, 1998). In the budding yeast Saccharomyces cere-
cant are lacking. In yeast, the primary requirement forvisiae, the silent mating±type loci and telomeric DNA
Sir2 is in gene silencing at three distinct chromosomalregions are packaged into silent chromatin (Nasmyth et
loci: the silent mating±type loci, the telomeric DNA re-al., 1981; Rine and Herskowitz, 1987; Gottschling et al.,
gions, and the rDNA repeats. These loci comprise all of1990). These chromosome domains share many distin-
the known silent chromatin in this organism. Studies ofguishing properties with heterochromatin of multicellu-
the possible enzymatic activity of Sir2 in yeast couldlar eukaryotes and are therefore thought to be analogous
therefore allow a direct examination of the role of thisto heterochromatin. Furthermore, one of the yeast si-
activity, if any, in a well-characterized cellular process.lencing proteins, Sir2, is involved in repression of hyper-
Here we show that the yeast Sir2 protein can use NAD1recombination and transcription of pol II reporter genes
as a donor to modify histones and itself in vitro. To
determine whether this enzymatic activity is required³ To whom correspondence should be addressed (e-mail: danesh@
for silencing, we mutated a conserved histidine in Sir2.hms.harvard.edu).
§ These authors contributed equally to this work. Mutation of the analogous histidine in SIRT2, a human
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Sir2-like protein, has been shown to abolish its enzy- observed using GST or the GST-Sir2-H364Y mutant pro-
tein (Figure 1C, lanes 1 and 3; Figure 1E, lane 2). Interest-matic activity (Frye, 1999). We show that this point muta-
tion abolishes the enzymatic activity of Sir2 in vitro. ingly, in the presence of histones, the self-modification
activity of Sir2, mentioned above, was significantly en-Significantly, the mutant Sir2 protein has no silencing
function in vivo at any of the above loci, even when hanced (Figure 1C, lane 2; Figure 1E, lane 1), but histones
had no effect on the labeling of BSA by Sir2 (data notoverexpressed from the strong GAL1 promoter. More-
over, immunoprecipitation experiments using whole-cell shown). Moreover, histones appeared to strongly induce
an NAD1 breakdown activity in Sir2; in the presence ofextracts and soluble chromatin show that the enzymati-
cally inactive protein is present in silencing complexes both Sir2 and histones, the free 32P-NAD1, which mi-
grates near the bottom of the gel, completely disap-and is associated with the same DNA domains as wild-
type Sir2. Consistent with these results, expression of peared (Figure 1C, lane 2). Instead of the free 32P-NAD1
band, we observed a 32P smear throughout the lane.the mutant protein disrupts silencing in SIR21 cells. Fi-
nally, we show that an antibody that is specific for mono- Extensive treatment of the reaction with proteinase K
had no effect on the appearance of this smear (FiguresADP-ribose can recognize a modified form of Sir2 that
requires the enzymatic activity of the Sir2 protein for its 1B and 1C, lane 5). However, the smear could be elimi-
nated by precipitation of the reaction with trichloroaceticgeneration, suggesting that Sir2 is an ADP-ribosyltrans-
ferase. acid (TCA) prior to its application to SDS polyacrylamide
gels (Figure 1E, lane 1). We do not know the chemical
nature of this smear but believe it unlikely that it rep-
resents the formation of protein-attached poly(ADP-Results
ribose) chains, as its appearance was not altered by
extensive treatment with proteinase K (Figures 1B andSIR2 Can Transfer 32P from NAD1 to Proteins
Including Histones and Itself 1C, lane 5), and it did not TCA precipitate with labeled
proteins (Compare Figure 1C, lane 1 with Figure 1E, lane1).Sir2-like proteins from human and E. coli have been
shown to catalyze the transfer of 32P from NAD1 to BSA Mono-ADP-ribosylation of proteins can also occur via
a chemical (nonenzymatic) reaction that involves the(Frye, 1999). We expressed the yeast Sir2 protein as a
fusion with glutathione S-transferase (GST) in E. coli, conjugation of ADP-ribose to protein lysine residues
through Schiff bases (Kun et al., 1976; Ueda and Ha-purified this fusion protein by chromatography on gluta-
thione-agarose, and tested if it could use 32P-a-NAD1 yaishi, 1985). To determine whether the observed label-
ing of proteins by 32P-NAD1 occurred through such aas a donor to label BSA. As a control for these experi-
ments, we constructed a point mutation in the SIR2 gene pathway, we performed the reactions in the presence
of NADase, which hydrolyzes NAD1 to nicotinamide andthat converts a conserved histidine at position 364 in
Sir2 to tyrosine (hereafter referred to as Sir2-H364Y). It ADP-ribose (Ueda and Hayaishi, 1985). If the labeling
of substrates in the reaction is chemical (for example,has previously been shown that mutation of the analo-
gous histidine in a human Sir2-like protein abolishes its through the reaction of 32P-ADP-ribose with lysine resi-
dues), then we would expect to observe an increase inenzymatic activity (Frye, 1999).
Incubation of GST-Sir2 with BSA in the presence of labeling of lysine-rich proteins such as histones when
NADase is present in the reaction. On the other hand,32P-NAD1 resulted in strong labeling of BSA. We could
easily detect labeling of as little as 150 ng of BSA in if labeling is enzymatic and requires intact 32P-NAD1, it
should be diminished in the presence of NADase. Addi-these experiments (Figure 1A, lanes 2±7). No labeling of
BSA was observed when GST-Sir2 was replaced with tion of NADase to the labeling reaction eliminated the
free 32P-NAD1 band, which runs near the bottom of thea GST-Sir2-H364Y mutant protein, indicating that the
observed enzymatic activity required wild-type Sir2 (Fig- gel, indicating that the enzyme was active in breaking
down NAD1 (Figure 1C, lane 4). NADase also eliminatedure 1A, lane 10). Similarly, no labeling was observed
when GST-Sir2 was replaced with GST or GST-Sir2- both the self-labeling and the histone-labeling activity
of Sir2, indicating that the observed labeling did notNterm (GST-Sir2N; Figure 1A, lanes 1, 8, and 11). In
addition to labeling of BSA, we observed a very weak result from a chemical reaction of substrate proteins
with 32P-ADP-ribose (Figure 1C, lane 4). The labeling oflabeling of GST-Sir2 itself, which migrates above the
both histones and Sir2 itself was also greatly diminishedBSA band at approximately 90 kDa (see Figure 1, lane 13).
in the presence of snake venom phosphodiesterase orAmong the candidates for physiological substrates of
excess unlabeled NAD1, but not unlabeled ATP (dataSir2 are other proteins that are involved in silencing.
not shown).These include Sir2 itself, the other Sir proteins, and his-
tones. In addition to being involved in silencing, histones
are known to be ADP-ribosylated in the cell (Golderer Recognition of a Modified Form of Sir2
and Grobner, 1991; Soman et al., 1991). We therefore by an Anti-ADP-Ribose Antibody
tested whether Sir2 could label a mixture of histones We noticed that GST-Sir2 fusion proteins purified from
using 32P-NAD1 as a donor. Incubation of GST-Sir2 with either E. coli or yeast migrated as doublets in SDS-
32P-NAD1 and histones derived from either Tetrahymena polyacrylamide gels. These doublets were most easily
(Figure 1C, lane 2; Figure 1E, lane 1) or calf thymus detectable in long electrophoretic runs of GST-Sir2
(Figures 1G and 1H) resulted in the modification of his- preparations from E. coli, which contained a minor
tones. Weak labeling of an unknown 67 kDa protein was slower migrating species and a major faster migrating
also observed in the Tetrahymena histone preparation species. Western blots with anti-GST and anti-Sir2 anti-
bodies recognized both bands, indicating the existence(Figure 1C, lane 2; Figure 1E, lane 1). No labeling was
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Figure 1. NAD1-Dependent Modification of
Proteins by Sir2
(A) Autoradiograms of 8.5% SDS polyacryl-
amide gels showing the modification of bo-
vine serum albumin (BSA) by GST-Sir2 using
32P-NAD1 as a donor. Reactions in lanes 2±7
contain 5 mg, 2.5 mg, 1.3 mg, 0.63 mg, 0.3 mg,
and 0.15 mg of BSA, respectively, and 2 mg
of GST-Sir2. Lane 1 contains 5 mg of BSA and
2 mg of GST. Lanes 8±13 contain 5 mg of BSA
and 0.5 mg of the indicated GST-Sir2 fusion
protein except for lane 13, which contains 2.5
mg GST-Sir2.
(B±E) Modification of Sir2 and histones by
GST-Sir2. (B) and (D) are Coomassie-stained
15% polyacrylamide gels showing the posi-
tion of GST (B, lane 1), GST-Sir2 (B, lane 2;
D, lane 1), and histones (B, lanes 1±4; D, lanes
1±2). (C) and (E) are autoradiograms of the
same gels shown in (B) and (D), respectively.
Reactions contained 0.5 mg of GST, GST-Sir2,
or GST-Sir2-H364Y (H364Y), and 3 mg of a
mixture of total histones from Tetrahymena.
Lanes 4 (B), 5 (B), and 1 (E) show the effect
of NADase, proteinase K, and TCA precipita-
tion on the labeling reaction, respectively.
TCA precipitated reactions (D and E) con-
tained 10 mg of BSA, which was added after
the completion of reactions; asterisk (*) indi-
cates the position of BSA in the TCA precipi-
tated reactions in (D).
(F±H) Modification of calf thymus histones by
GST-Sir2. Same conditions as in (B)±(E), ex-
cept that reactions contained 3 mg calf thy-
mus histones instead of Tetrahymena histones.
GST-Sir2 was prepared from cells containing
pDM111 (lane 1, GST-Sir2) or pDM111a (lane
2, GST-Sir2a). Dash marks on the left indicate
the position of prestained molecular weight
markers.
of a modified form of Sir2 (Figure 2A, lane 1, and data and the completion of Western detection (Figures 2C
and 2D, lane 1). The band recognized by the anti-ADP-not shown). However, the slower migrating species
(GST-Sir2-s) was completely absent in Sir2-H364Y prep- ribose antibody closely aligned with the slower migrat-
ing GST-Sir2 species on the Coomassie-stained blotarations that are enzymatically inactive (Figure 2A, com-
pare lanes 1 and 2). Thus, the generation of GST-Sir2-s (Figure 2D, lane 1). Finally, we probed Western blots
containing the same GST-Sir2 fusion proteins used inrequired the enzymatic activity of Sir2 and could result
from an automodification activity of overexpressed the above experiments with a more sensitive and spe-
cific affinity purified anti-ADP-ribose antibody (MeyerGST-Sir2 in E. coli. The identity of the adduct on GST-
Sir2-s may therefore indicate the nature of the enzymatic and Hilz, 1986). This antibody also strongly recognized
wild-type GST-Sir2 purified from either E. coli or yeastactivity of Sir2. We tested whether this adduct could
be recognized by an anti-mono-ADP-ribose antibody (Figure 2E, lanes 1 and 3, respectively), but did not rec-
ognize the mutant GST-Sir2-H364Y protein (Figure 2E,generated by Meyer and Hilz (1986). Figure 2B (lane 1)
showed that an anti-ADP-ribose antiserum specifically lane 2). Together, these results indicated that GST-
Sir2-s was an ADP-ribosylated form of Sir2 and that Sir2recognized the GST-Sir2-s band but not the faster mi-
grating GST-Sir2 band or the GST-Sir2-H364Y protein could auto-mono-ADP-ribosylate itself in vivo.
(Figure 2B, lanes 1 and 2). We note that the blot contains
about 50- to 100-fold more GST-Sir2 and GST-Sir2- The Enzymatic Activity of Sir2 Is Required
for Silencing at the Silent Mating±TypeH364Y than GST-Sir2-s (see Figure 2A, left), verifying
the specificity of the antibody for the modified form Loci, Telomeres, and rDNA Repeats
We next tested whether the observed enzymatic activityof Sir2. The anti-ADP-ribose antibody also recognized
GST-Sir2 purified from yeast (Figure 2D, lane 2). The of Sir2 was required for its silencing function. We con-
structed plasmids that contained either the wild-typeGST-Sir2 doublets in preparations from yeast were diffi-
cult to resolve on Western blots of SDS polyacrylamide SIR2 or the H364Y mutant SIR2 gene. These plasmids
were transformed into strains in which the endogenousgels (Figure 2C, lane 2), but could be visualized by Coo-
massie staining of the blots after transfer to membrane SIR2 gene was deleted (sir2D). We first tested whether
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Figure 2. An Anti-Mono-ADP-Ribose Anti-
body Recognizes a Modified Form of Sir2
Western blots showing the detection of E.
coli produced GST-Sir2 proteins by anti-GST
(a-GST, A) and anti-ADP-ribose (a-ADPR, B)
antibodies. Approximately 1 mg of each GST-
Sir2 (lane 1) or GST-Sir2-H364Y (lane 2) was
loaded on an 8.5% SDS polyacrylamide gel,
transferred to membrane, and probed with
each antibody. The slower migrating GST-
Sir2-s is recognized by both a-GST (A) and
a-ADPR (B), whereas the more abundant
faster-migrating GST-Sir2 is only recognized
by a-GST (A). In (C), GST-Sir2 was expressed
in yeast under the control of the GAL1 pro-
moter, and after purification, 1 mg was applied
to an 8.5% SDS polyacrylamide gel, blotted,
and probed with either a-GST (C, lane 2) or
a-ADPR (D, lane 2). The a-ADPR antibody
recognized a band (D, lane 2) that runs slightly
above the main GST-Sir2 band recognized by
a-GST (C, lane 2) and aligns with the slower
migrating Coomassie-stained GST-Sir2 band
(D, lane 1). (E) Western blot showing that an
affinity-purified anti-mono-ADP-ribose anti-
body recognizes GST-Sir2 purified from E.
coli (lane 1) or yeast (lane 3), but not the GST-
Sir2-H364Y protein (lane 2, purified from E.
coli). In (C)±(E), ª-º indicates the position of
one of the prestained molecular weight mark-
ers (62 kDa) used to align Western blot signals
with Coomassie-stained bands. The slight
difference in the migration of the main GST-
Sir2 band and the GST-Sir2-H364Y proteins
(lanes 1 and 2 in A) is due to the presence of
9 additional amino acids between the GST
and SIR2 open reading frames in pDM111
(see Experimental Procedures). These extra
amino acids had no effect on the enzymatic
activity of GST-Sir2 or its recognition by the
a-ADPR antibody.
the mutant protein is expressed at a similar level as was absolutely required for the telomeric and rDNA si-
lencing functions of Sir2.wild-type Sir2 in the cell. Western blots of yeast extracts
prepared from strains containing either wild-type Sir2 Derepression of silent mating±type information at
HML and HMR results in loss of haploid cell identity andor the Sir2-H364Y protein were probed with an anti-
Sir2 antibody and showed that the Sir2-H364Y mutant inability of haploid yeast cells to mate and form diploids
(Herskowitz, 1988). The mating assay based on selectionprotein was expressed to the same level as wild-type
Sir2 (Figure 3A). To assess telomeric and rDNA silencing, for diploid cells provides an extremely sensitive assay
for assessing silencing at the silent mating±type loci.the host strains also contained URA3 reporter genes
inserted either near a telomere or within the rDNA re- We therefore used this assay to determine whether the
enzymatic activity of Sir2 is also required for mating-peats (Gottschling et al., 1990; Smith and Boeke, 1997).
In these experiments, silencing of the URA3 reporter type silencing. The high sensitivity of the mating assay
was also expected to reveal whether the Sir2-H364Ygene results in loss of growth on medium lacking uracil,
but allows the growth of the Ura2 cells on medium that mutant protein had any residual silencing function. While
the wild-type SIR2 plasmid fully complemented the mat-contains the compound 5-FOA, which is toxic to Ura1
cells. While the plasmid containing the wild-type SIR2 ing defect of the sir2D strain, the SIR2-H364Y plasmid
showed no complementation activity (Figure 3D). Thus,gene fully complemented the deletion of SIR2 for both
telomeric silencing (Figure 3B) and rDNA silencing (Fig- histidine 364 is required for silencing at the silent mating±
type loci. Together, the above experiments demonstrateure 3C, compare Vector row with pSIR2-LEU2 row), the
SIR2-H364Y plasmid showed no detectable comple- that the Sir2-H364Y protein has no silencing function.
We hypothesized that the enzymatically inactive Sir2 pro-mentation activity and behaved like the vector backbone
(Figures 3B and 3C, compare Vector row with pH364Y- tein may become incorporated into silencing complexes.
In such a case, the mutant protein would interfere withLEU2 row). These results indicated that histidine 364
ADP-Ribosylation and Transcriptional Silencing
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Figure 3. The Enzymatic Activity of Sir2 Is
Required for Silencing at the Silent Mating
Type Loci, Telomeres, and the rDNA Repeats
(A) Western blot of whole-cell yeast extracts
from the same strains as those used for telo-
meric silencing assays in (B) probed with an
anti-Sir2 antibody. sir2D, a sir2 deletion strain
transformed with a LEU2 vector; Sir2, a sir2
deletion strain transformed pSIR2-LEU2;
Sir2-H364Y, a sir2 deletion strain transformed
with pSir2-H364Y.
(B) Telomeric silencing in a sir2D strain con-
taining a URA3 reporter gene near a telomere
(Gottschling et al., 1990). A plasmid con-
taining the wild-type SIR2 gene restores si-
lencing and allows growth on 5-FOA con-
taining media (middle row). No growth on
5-FOA medium is observed when the sir2D
strain is transformed with either vector alone
(top row) or the pSir2-H364Y plasmid (bottom
row).
(C) Same as in (B) but with the URA3 reporter
gene located within the rDNA repeats (Smith
and Boeke, 1997). The plasmid containing the
wild-type SIR2 gene restores rDNA silencing
and causes loss of growth on -LEU-URA me-
dium (C, middle row). The pH364Y-LEU2 plas-
mid behaves like the empty vector.
(D) A plasmid containing the H364Y mutant
SIR2 gene (pH364Y-LEU2) is unable to com-
plement the inability of a sir2D strain to mate
(bottom row).
silencing in wild-type cells by competing with wild-type row on -LEU medium). Interestingly, overexpression of
Sir2-H364Y caused only a slight growth defect, sug-Sir2 for incorporation into silencing complexes. To test
this hypothesis, we expressed the Sir2-H364Y protein, gesting that the enzymatic activity of Sir2 contributes
to its overexpression toxicity (Figure 4C).either under the control of its own promoter or overex-
pressed from the strong GAL1 promoter, in SIR21 cells.
Remarkably, expression of the mutant protein under the
control of its own promoter nearly abolished telomeric The Enzymatically Inactive Sir2 Protein Is Incorporated
into Silencing Complexes and Associatessilencing and slightly reduced rDNA silencing in SIR21
cells (Figures 4A and 4B). However, rDNA silencing in with Silent Chromatin Domains
Sir2 is associated with Sir4 and Net1 in two distinctSIR21 cells was nearly completely disrupted when Sir2-
H364Y was overexpressed from the GAL1 promoter (Fig- silencing complexes that act in mating-type/telomeric
and rDNA silencing, respectively (Moretti et al., 1994;ure 4C, compare pGAL-GST-SIR2 row with pGAL-GST-
H364Y row). This strong dominant-negative phenotype Moazed et al., 1997; Strahl-Bolsinger et al., 1997; Shou
et al., 1999; Straight et al., 1999). The results presentedis likely to result from incorporation of an inactive Sir2
into silencing complexes, since substitution of histidine in Figure 4 suggested that Sir2-H364Y could participate
in formation of both types of silencing complexes. To364 with tyrosine does not interfere with the expression
or stability of the mutant protein (see below, Figure 5). test this idea more directly, either wild-type or H364Y
mutant Sir2 proteins were immunoprecipitated fromFurthermore, as previously reported (Holmes et al.,
1997), overexpression of Sir2 from the strong GAL1 pro- whole-cell yeast extracts and the immunoprecipitates
were tested for the presence of Sir4 and Net1. Consis-moter was toxic and resulted in a severe growth defect
(Figure 4C, compare Vector row with pGAL1-GST-SIR2 tent with the dominant-negative phenotype described
Cell
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Figure 4. Disruption of Silencing by an Enzy-
matically Inactive Sir2 Protein
(A) SIR21 cells containing a URA3 reporter
gene near a telomere (Gottschling et al.,
1990) were transformed with empty vector
(pRS315, top row), a plasmid containing the
wild-type SIR2 gene (pSIR2-LEU2, middle
row), or a SIR2 gene encoding the H364Y mu-
tant protein (pH364Y-LEU2, bottom row). Ex-
pression of the mutant protein disrupted telo-
meric silencing, resulting in loss of growth
on -LEU15-FOA medium.
(B) SIR21 cells containing a URA3 reporter
gene inserted within the rDNA repeats (Smith
and Boeke, 1997) were transformed with the
same set of plasmids as in (A) or with GAL1-
GST-SIR2 overexpression plasmids (C). Ex-
pression of H364Y Sir2 protein from its own
promoter causes a slight reduction in rDNA
silencing (B, compare pSIR2-LEU2 row with
pH364Y-LEU2 row), but its overexpression
from the GAL1 promoter strongly disrupts
rDNA silencing (C, compare pGAL1-GST-
SIR2 row with pGAL1-GST-H364Y row).
above, both wild-type and Sir2-H364Y proteins immuno- 1997) to determine whether silencing complexes con-
taining the enzymatically inactive Sir2-H364Y proteinprecipitated Sir4 and Net1 with similar efficiencies (Fig-
ures 5A±5C). No Sir4 or Net1 was present when anti- can associate with their usual target domains. We pre-
cipitated formaldehyde cross-linked soluble chromatinSir2 immunoprecipitation was carried out using an ex-
tract from a sir2D strain (Figures 5A±5C). These results from sir2D strains expressing plasmid encoded wild-
type Sir2 or mutant Sir2-H364Y proteins. SIR21 andindicated that the mutant protein was incorporated into
silencing complexes with a similar efficiency as wild- sir2D strains were used as controls. As previously re-
ported (Gotta et al., 1997; Strahl-Bolsinger et al., 1997),type Sir2.
We next used the chromatin cross-linking and immu- immunoprecipitation with an anti-Sir2 antibody followed
by PCR analysis showed that Sir2 was associated withnoprecipitation assay (ChIP) (Strahl-Bolsinger et al.,
Figure 5. The Enzymatically Inactive Sir2 Is Incorporated into Silencing Complexes and Is Associated with Chromatin
(A±C) The Sir2 protein was immunoprecipitated from sir2D strains containing a plasmid backbone (lane1), a plasmid expressing the wild-type
Sir2 protein (lane2), or the Sir2-H364Y mutant protein (lane 3). Western blots were probed with anti-Sir2 (A), anti-Net1 (B), and anti-Sir4 (C)
antibodies.
(D and E) Immunoprecipitation of chromatin from formaldehyde cross-linked cells using an anti-Sir2 antibody showing the association of Sir2
and Sir2-H364Y proteins with rDNA (D) and telomeric DNA regions (E). PCR amplification was performed with 2.5-fold serial dilution of
immunoprecipitated DNA corresponding to 1/50th, 1/125th, and 1/250th of immunoprecipitated DNA. Input DNA represents PCR amplification
of approximately 1/10,000th of crude chromatin used for each immunoprecipitation reaction.
ADP-Ribosylation and Transcriptional Silencing
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Figure 6. Schematic Diagram Showing the
Location of the Conserved Core Domain of
Sir2
Shaded region, amino acids 241 to 459, is
conserved among Sir2-like proteins (see
Brachmann et al., 1995 and Sherman et al.,
1999 for detailed alignments). The highly con-
served region between amino acids 255 to 275 has weak similarity to part of the NAD1 binding domain in 6-phosphogluconate dehydrogenases.
The asterisk (*) indicates the location of the invariant histidine 364; mutation of this residue abolishes the enzymatic activity of Sir2 and its
silencing function. Bold letters indicate residues that are invariant or highly conserved in all Sir2-like proteins. See text for further discussion.
silent chromatin regions within the rDNA cluster and Three lines of evidence suggest that Sir2 is a mono-
ADP-ribosyltransferase. First, a modified form of Sir2near a telomere, but not with active genes such as ACT1
and CUP1 (Figures 5D and 5E, and data not shown). could be recognized by an antibody that has much
higher affinity for mono-ADP-ribose than for poly(ADP)-The Sir2-H364Y protein was also associated with DNA
fragments corresponding to silent chromatin domains ribose chains (Meyer and Hilz, 1986). Second, modifica-
tion of proteins by Sir2 causes only a slight shift in theirbut with a lower efficiency than wild-type Sir2. Com-
pared to wild-type Sir2, the efficiency of coprecipitation mobility in SDS-polyacrylamide gels, even when high
concentrations of NAD1 are included in the reaction.of DNA fragments with the Sir2-H364Y protein was re-
duced about 2.5-fold for rDNA fragments (Figure 5D) This is in contrast to dramatic shifts observed in the
mobilities of proteins that are poly(ADP)ribosylatedand about 7-fold for telomeric DNA fragments (Figure
5E). Because silencing is completely abolished in H364Y (Ueda and Hayaishi, 1985; Smith et al., 1998). Third, all
known poly(ADP)ribose polymerases are inhibited bymutant strains but the Sir2-H364Y protein is still associ-
ated with rDNA and telomeric chromatin, we conclude 3-aminobenzamide (Ueda and Hayaishi, 1985), which
has no effect on the enzymatic activity of Sir2 (D. M.,that the enzymatic activity of Sir2 is required for a post-
initiation step in assembly of silent chromatin. unpublished data).
If Sir2 uses NAD1 as a cofactor to modify histones or
other proteins in a step that is required for silencing, asDiscussion
the results presented here suggest, then defects in
NAD1 biosynthesis resulting in changes in the intracellu-The experiments reported here demonstrate that the
yeast Sir2 protein has an enzymatic activity that uses lar levels of NAD1 may be expected to affect the effi-
ciency of silencing in yeast. Indeed, Smith et al. haveNAD1 as a donor to covalently modify protein sub-
strates. In addition to modifying itself, Sir2 can modify discovered that deletion of NPT1, encoding an enzyme
that catalyses the formation of nicotinic acid mono-the core histones in vitro, suggesting that histones may
be among the in vivo targets of Sir2. The identity of nucleotide, a precursor in NAD1 biosynthesis, disrupts
silencing in yeast (J. Boeke, personal communication).the donor compound (NAD1) and the recognition of a
modified form of Sir2, which requires enzymatically ac- These results suggest that the efficiency of silencing is
extremely sensitive to a reduction in the intracellulartive Sir2 for its generation, by an anti-ADP-ribose anti-
body suggest that the relevant enzymatic activity is pools of NAD1.
Sir2-like proteins have no obvious sequence similarityADP-ribosylation. We further show that the loss of this
enzymatic activity correlates with the loss of silencing to any of the known ADP-ribosyltransferases and appear
to define a distinct class of enzymes. All proteins in thisat the silent mating±type loci, telomeric DNA regions,
and the rDNA repeats. These results provide an example class contain a conserved 250 amino acid region, which
corresponds to the C-terminal domain of yeast Sir2of a chromatin-associated enzymatic activity that is ab-
solutely required for transcriptional repression. (Brachmann et al., 1995) (Figure 6). The enzymatic activ-
ity reported here and observed by Frye (1999) lies withinADP-ribosylation involves the transfer of an ADP-
ribose moiety from NAD1 to acceptor amino acids in this domain of Sir2. Interestingly, a 39 amino acid region
within the core domain, centered around the conservedprotein substrates (Ueda and Hayaishi, 1985). The most
prevalent form of this modification is mono-ADP-ribosy- GAGxSxxxG sequence (Figure 6), is weakly similar to a
39 amino acid region of bacterial 6-phosphogluconatelation, which involves the transfer of a single ADP-ribose
moiety to amino acid side chains, typically to form an dehydrogenases (33% identical, 56% similar), which use
NADP1 (and with much lower efficiency, NAD1) as aN-glycosidic bond with either arginine or asparagine
and in certain cases with a modified amino acid side cofactor to catalyze the conversion of 6-phosphogluco-
nate to ribulose 5-phosphate (Bisercic et al., 1991). Thechain, diphthamide. The best characterized mono-ADP-
ribosylation enzymes are bacterial toxins, such as diph- NAD1-binding site in dehydrogenases is composed of
two similar domains that bind to the nicotinamide andtheria and cholera toxins, which interfere with translation
and regulation of cAMP levels, respectively. A second adenine moieties in NAD1. The similarity between Sir2
and these dehydrogenases appears to be limited to theclass of enzymes in this family are poly(ADP)ribosylation
enzymes (PARPs), which have only been identified in adenine-binding half of the NAD1-binding domain (Phil-
lips et al., 1998). The histidine that is required for themulticellular eukaryotes (Ueda and Hayaishi, 1985).
PARPs usually catalyze the addition of poly(ADP)ribose enzymatic activity of Sir2 is conserved in all Sir2-like
proteins and is usually followed by glycine and serinechains via an O-glycosidic bond to either a glutamic
acid side chain or the polypeptide carboxy terminus. or threonine (Figure 6). We note that the active sites
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Table 1. List of Yeast Strains Used in This Study
Strain Genotype Source
Y1 (JRY2334) MATa ade2-1 can1-100 his3-11 leu2-3.112 trp1 ura3-1 GAL J. Rine
Y3 (JRY3433) Y1, sir2::HIS3 J. Rine
Y10 (BJ5459) MATa ura3-52 trp1 lys2-801 leu2D1 his3D200 pep4::HIS3 prb1D1.6R can1 GAL E. Jones
Y235 (UCC1001) MATa ura3-52 lys2-801 ade2-1010 trp1D his3-D200 leu2-D1 TEL adh4::URA3 D. Gottschling
Y1195 Y235, pRS315 This study
Y1197 Y235, pSIR2-LEU2 This study
Y1199 Y235, pH364Y-LEU2 This study
Y1240 Y235, pGST-LEU2 This study
Y1242 Y235, pGST-SIR2-LEU2 This study
Y1244 Y235, pGST-H364Y-LEU2 This study
Y1201 Y235, sir2D, pRS315 This study
Y1203 Y235, sir2D, pSIR2-LEU2 This study
Y1205 Y235, sir2D, pH364Y-LEU2 This study
Y1218 Y235, sir2D, pGST-LEU2 This study
Y1220 Y235, sir2D, pGST-SIR2-LEU2 This study
Y1222 Y235, sir2D, pGST-H364Y-LEU2 This study
Y236 (UCC1003) MATa ura3-52 lys2-801 ade2-1010 trp1D his3-D200 leu2-D1 adh4::URA3 D. Gottschling
Y1236 Y236, pRS315 This study
Y480 (JS128) MATa his3D200 leu2D1 ura3-167 RDN1::Ty1-mURA3 J. Smith and J. Boeke
Y1206 Y480, pRS315 This study
Y1208 Y480, pSIR2-LEU2 This study
Y1210 Y480, pH364Y-LEU2 This study
Y1224 Y480, pGST-LEU2 This study
Y1226 Y480, pGST-SIR2-LEU2 This study
Y1228 Y480, pGST-H364Y-LEU2 This study
Y1230 Y480, sir2D, pGST-LEU2 This study
Y1232 Y480, sir2D, pGST-SIR2-LEU2 This study
Y1234 Y480, sir2D, pGST-H364Y-LEU2 This study
Y1212 Y480, sir2D, pRS315 This study
Y1214 Y480, sir2D, pSIR2-LEU2 This study
Y1216 Y480, sir2D, pH364Y-LEU2 This study
Y478 (JS122) MATa his3D200 leu2D1 ura3-167 ???::TY1-mURA3 J. Smith and J. Boeke
Y1238 Y478, pRS315 This study
of many poly- and mono-ADP-ribosylases contain an What role might the enzymatic activity of Sir2 play in
gene silencing? We have shown that the enzymaticallyHGS/T sequence, where the histidine side chain hydro-
gen bonds with the 39-hydroxyl group of the adenylate inactive Sir2-H364Y protein can assemble into silencing
complexes with Sir4 and Net1, respectively, and thatribose in NAD1 (Ruf et al., 1998; Kickhoefer et al., 1999).
The histidine residue at position 364 of Sir2 may play a the mutant protein is associated with the same DNA
domains as wild-type Sir2. These results suggest thatsimilar role in binding NAD1. The significance of these
limited sequence similarities, if any, will only become Sir2 modifies a chromatin component after its recruit-
ment to DNA and that this modification is either directlyclear when the crystal structure of a Sir2-like protein is
determined. or indirectly responsible for silencing. A first step in
understanding the role of this modification is the identifi-Previous studies have demonstrated that the Sir2 pro-
tein is a component of silent chromatin regions at the cation of the true physiological substrates of Sir2.
Among the candidate targets of Sir2 are the histones,mating-type loci, telomeric DNA regions, and the rDNA
repeats (Gotta et al., 1997; Strahl-Bolsinger et al., 1997). which play a pivotal role in the assembly of silent chro-
matin domains (Kayne et al., 1988; Hecht et al., 1995,Sir2 also appears to be able to act more globally when
it is overexpressed. Thus, overexpression of Sir2 from 1996; Bryk et al., 1997), and other proteins that are re-
quired for silencing. Sir2 might act on a common targetthe yeast GAL1 promoter causes a severe growth defect
and reduced viability (Holmes et al., 1997). The basis that is involved in silencing at both mating-type/telo-
meric and rDNA regions, or it might modify differentfor this toxicity is unknown, but it is accompanied by a
general decrease in histone acetylation (Braunstein et targets, depending on the locus to which it is recruited.
The former possibility points to histones and Sir2 itselfal., 1993) and an increase in the rate of chromosome
loss (Holmes et al., 1997), suggesting that Sir2 toxicity as the likely targets of Sir2, as both histones and Sir2
are involved in silencing at all of the silent loci. Althoughresults from a global alteration in chromosome struc-
ture. One exciting possibility is that ADP-ribosylation of the activity of Sir2 under the reaction conditions em-
ployed in our experiments is rather promiscuous, his-histones by Sir2 directly inhibits histone acetylation by
preventing histone acetylases from gaining access to tones and Sir2 itself were among the best substrates for
its enzymatic activity in our in vitro labeling experiments.their recognition sites in histones and that this is the
underlying cause of Sir2 toxicity. Consistent with this Furthermore, a fraction of overexpressed Sir2 protein
purified from yeast is an ADP-ribosylated form that re-idea, overexpression of the enzymatically inactive Sir2
protein had little effect on growth (see Figure 4C). quires enzymatically active Sir2 for its generation. These
ADP-Ribosylation and Transcriptional Silencing
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Enzyme Activity Assaysresults identify Sir2 itself as one target of Sir2 activity,
Reactions were carried out in a volume of 10 ml containing 0.5 mgbut the physiological consequences of this self-modifi-
to 2 mg of each GST fusion protein, 0.1 mg to 5 mg of BSA, or 3 mgcation and whether Sir2 acts on histones in vivo remain
of calf thymus (Boehringer Mannheim) or Tetrahymena (generous
to be determined. An exciting possibility is that the re- gift of Nima Mossamaparast and David Allis) histones as indicated,
cruitment of Sir2 to sites that initiate silencing activates and 3 mCi of 32P-NAD1 (1000 Ci/mmol, Amersham Pharmacia) in 50
mM Tris-HCl, pH 8.0 (at 228C), 150 mM NaCl, 10 mM DTT. GST-its enzymatic activity in a step that requires an interac-
Sir2 proteins were also active in reaction buffers containing 50 mMtion between Sir2 and histones and involves the auto-
Glycine-KOH, pH 9.0, or 50 mM HEPES-KOH, pH 7.6 (Frye, 1999),ADP-ribosylation of Sir2. Subsequently, Sir2 may modify
instead of Tris-HCl. After incubation for 1 hr at 378C, reactions werehistones or other silencing factors to promote gene si-
stopped by the addition of 90 ml ice-cold 22% trichloroacetic acid
lencing. Understanding the precise function of the enzy- (TCA), incubated on ice for 15 min, and centrifuged at 13,000 g for
matic activity of Sir2 and its effect on chromatin struc- 15 min. The pellets were resuspended in 20 ml 1.53 SDS sample
buffer, heated to 1008C for 3 min, and 10 ml was loaded onto 8.5%ture should provide valuable lessons on how covalent
or 15% SDS polyacrylamide gels. Ten micrograms of BSA wasmodification of chromatin by mono-ADP-ribosylation
added to some reactions as a carrier before TCA precipitation.can regulate gene expression.
Where indicated, NADase (1 ml, 50 units/ml, Sigma) was added to
the reactions at the same time as Sir2, and proteinase K (1 ml, 2
Experimental Procedures mg/ml, Boehringer Mannheim) was added at the end of the reaction
with an additional incubation time of 30±60 min at 378C. After electro-
Strains, Plasmids, and Other Reagents phoresis, polyacrylamide gels were stained with Coomassie brilliant
All the yeast strains used in this study are listed in Table 1. pGAL- blue, destained, dried on Whatman paper, and exposed to Kodak
GST was constructed by ligation of an XbaI/BamHI fragment con- XAR5 film for 3±12 hr at room temperature.
taining the GAL1 promoter driving GST from pRD56 (kind gift of
Ray Deshaies, California Institute of Technology) into XbaI/BamHI-
Silencing Assaysdigested pRS315. The entire SIR2 open reading frame was PCR
Telomeric and rDNA silencing assays were performed as previouslyamplified as an EcoRI fragment and ligated into the EcoRI site of
described (Aparicio et al., 1991; Smith and Boeke, 1997). CulturespRD56 in frame with the C terminus of GST to generate pDM114a.
of the appropriate synthetic selective media were inoculated withA XbaI/XhoI fragment containing GAL1-GST-SIR2 was then ligated
overnight cultures of desired yeast strains and grown to log phaseinto XbaI/XhoI-digested pRS315 to generate pGAL1-GST-SIR2.
(A660 of about 1) at 308C. Three microliters of 10-fold serial dilutionsThe H364Y mutation was generated by overlap PCR as follows:
of each culture (in water) were spotted onto SD-LEU, SD-LEU-URA,SIR2 fragments were generated using the overlapping primers JT7
and SD-LEU15-FOA plates. For galactose induction dextrose in the(59 GTGCTATGGCTCTTTTGCTAC 39) and JT8 (59 GCCATAGCACTG
medium was replaced with galactose. Plates were photographedCACCAGTTTATC 39) and the outside primers JT9c (59 GGCGAATTC
after 2±3 days of growth at 308C. Mating assays were performed asGGAAGTGCAATATCTGTC 39) and JT10 (59 CGCGAATTCATCAC
previously described (Sprague, 1991).GATTAATCAGGACTTG 39). Underlined letters indicate the position
at which a point mutation was introduced. Separate PCR reactions
were performed with primer pairs JT7/JT10 and JT8/JT9c (30 cycles
Immunoprecipitation Reactions and Western Detection
of 948C for 30 s, 558C for 30 s, and 728C for 2 min). Portions of
One liter cultures of yeast strains (Y1201, Y1203, and Y1205) were
the resulting PCR products were then mixed and reamplified with
grown to mid-log phase in SD-LEU medium (A660 of 1.5, approxi-
primers JT9c and JT10. The final PCR product containing the appro-
mately 3 g/l). Cells were harvested by centrifugation, washed with
priate point mutation was digested with StuI and BglII and used to
ice-cold water, and flash frozen in liquid nitrogen. Cell lysis, immuno-
replace a StuI/BglII fragment in pGAL/GST-Sir2 to generate pGAL-
precipitation, and transfer to PVDF membranes were performed
GST-H364Y. A BglII±StuI fragment encoding the C terminus of Sir2
essentially as described previously (Moazed et al., 1997). Mem-
and containing the H364Y mutation was then subcloned into the
branes were blocked with 5% nonfat dry milk in 20 mM Tris-HCl,
BglII±StuI sites of pSIR2-LEU2, which contains the entire SIR2 geno-
pH 7.5, 150 mM NaCl, 0.05% Tween-20 and probed with 1:5000
mic region in the pRS315 backbone, to generate pH364Y/LEU2.
dilution of rabbit anti-Sir2 and anti-Sir4 affinity-purified antibodies
All PCR-generated regions were entirely sequenced to ensure the
(D. M., unpublished data), and 1:1000 dilution of a rabbit anti-Net1
absence of PCR-introduced errors. The entire SIR2 open reading
antibody (J. H. and D. M., unpublished data). Secondary detection
frame was PCR amplified as an EcoRI fragment and subcloned into
was performed using horseradish peroxidase coupled donkey anti-
pGEX-1B to generate a GST-Sir2 fusion protein (pDM111). pGEX-
rabbit antibodies (Amersham) and the Renaissance enhanced
1B is a derivative of pGEX-1 (Smith and Johnson, 1988) containing
chemiluminescence detection system (NEN).
an insertion within its BamHI site that encodes thrombin and heart/
ChIP experiments were carried out as previously described
muscle kinase recognition sites (D. M., unpublished data). pDM360
(Strahl-Bolsinger et al., 1997) using a monoclonal anti-Sir2 antibody.
was constructed by subcloning the EcoRI±XhoI SIR2/H364Y frag-
Primers and other details were as described in Straight et al. (1999).
ment from pGAL1-GST-H364Y/LEU2 into pGEX-4T-1 (to make GST-
For detection of ADP-ribosylated forms of Sir2, approximately 1
Sir2-H364Y). GST fusion proteins constructed using pGEX-1B are
mg of GST-Sir2 fusion proteins purified from either yeast or E. coli
9 amino acids longer than GST fusion proteins constructed using
were loaded onto 8.5% SDS polacrylamide gels, and after electro-
pGEX-4T-1 (due to insertion of the heart muscle kinase site). In order
phoresis, blotted onto PVDF membranes. Several identical lanes
to generate GST-Sir2 fusion proteins that were identical except for
were run on the same gel, the resulting blot was then cut into several
a single amino acid substitution at position 364 of Sir2, the BglII±XhoI
longitudinal pieces, which were then probed separately with affinity-
fragment at the C terminus of SIR2 in pDM360 (containing the H364Y
purified rabbit anti-ADP-ribose (1:10,000 dilution, Meyer and Hilz,
mutation) was replaced with the corresponding wild-type SIR2 BglII±
1986), anti-GST (1:5,000), or anti-Sir2 (1:5,000) antibodies. After incu-
XhoI fragment to generate pDM111a.
bation with secondary antibodies and detection by chemilumines-
cence (described above), blots were stained with Coomassie, and
Purification of GST-Sir2 and GST-Sir2-H364Y the Coomassie-stained bands and Western signals were aligned
GST-Sir2 and GST-Sir2-H364Y were purified from DH5a cells trans- using stained molecular weight markers as standards.
formed with pDM111a (or pDM111) and pDM360, respectively, as
previously described (Moazed and Johnson, 1996). Identical yields
were obtained for GST-Sir2 and GST-Sir2-H364Y. GST-SIR2 and Acknowledgments
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